Pharma Field Sales - Cardiometabolic Care Specialist I - P Corona California

About the Department The Cardiometabolic Care Sales Team is at the forefront of US sales efforts for Novo Nordisk’s robust cardiometabolic product portfolio, which includes world-class therapies for treating multi-morbid conditions such as diabetes, obesity, and the reduction of major adverse cardiovascular events. Our ambition is to advance broad cardiometabolic disease management by bringing exciting new therapies to market to improve patient outcomes. As a team member, you will connect therapies to new specialties, build cardiometabolic advocates, and apply learnings that impact local markets and the organization in a cross-collaborative way. The Position Assumes responsibility for achieving sales goals by implementing marketing and sales strategies aimed at effectively selling and promoting Novo Nordisk’s portfolio of products to HCPs and other office staff. Relationships Externally, the CMCS maintains relationships with physicians, physician assistants, nurse practitioners, medical assistants, pharmacists, nurses and other paramedical customers and current co-promotion partners. Internally, the CMCS reports to the District Business Manager of the specific sales territory. The CMCS also interacts and collaborates on a regular basis with other field-based employees covering the same geographic areas, particularly the territory partner. Essential Functions Demonstrates competencies on a consistent basis with territory level impact Demonstrates understanding of the local payer market including Medicare, Commercial and Medicaid benefit designs, Payer Coverage, Prescription Coverage Requirements, Step Therapy, Coverage Gap, Copays, and Deductibles and the impact on customer decisions Demonstrates understanding of territory customer groups and affiliations such as IPAs, Medical Groups, Health Systems, and Local Clinics and uses this to identify business opportunities and tailor approach to customers Analyze bidding policies/contracts in order to influence formulary status, as applicable May analyze impact of managed care in the territory and its effect on prescribing decisions, and modify sales and promotion strategies May develop and utilize relationships with specialists, key hospital decision-makers, and other individuals who make or influence the purchasing, prescribing, and/or formulary decisions (and others within the influence map) Researches, understands and tailors account plans based on stakeholders and accounts business practices Utilizes understanding of the territory market including current market conditions, competitive market trends, priorities, and patient needs to develop and execute territory business plans Develops and implements plans to gain access to build and maintain business-relevant relationships with customers: prescribers, support staff, pharmacies, and clinic administrators to gain access and drive business impact by collaborating around the clinical management of patients and offering NNI-approved solutions Demonstrates professionalism and a customer-focused approach with internal and external stakeholders by actively listening, identifying and addressing customers and patients’ needs, and keeping commitments Develops and sustains internal relationships by collaborating across functions (e.g. Market access, Speciality Sales, etc.) by proactively sharing appropriate knowledge and business opportunities to impact customers Demonstrates proficiency in implementing the Novo Nordisk Edge Selling Model with external customers and during company sponsored meetings: Strategic Planning- Pre-Call Planning, Creates Customer Engagement-Open Purposefully, Uncover Needs, Adapts Approach-Provide Solutions and Deliver Core Messages, Resolve Objections, Call to Action-Gain Commitment with Impact, Transition Utilizes analytical tools to evaluate territory business opportunities and create territory business plans to engage customers and gain commitment to utilize NNI products for appropriate patient types utilizing payer opportunities, brand/sales strategies and objectives in order to meet territory sales goals. Proactively communicates and coordinates with relevant internal stakeholders (Pod team, PDBM, RBD, etc.) to implement plans and define roles and responsibilities to ensure accountability. Exercises prudent control over samples and other company property in accordance with company policies and procedures and legal requirements. Manages discretionary territory budget and marketing promotional program budget to support territory sales goals. Demonstrates a clear and thorough understanding of the disease state(s) and its impact on customers and patients including the full range of treatment options available including a detailed knowledge of both NNI and competitor products. Demonstrates thorough knowledge of all promoted NNI approved clinical studies and the skill to engage customers (prescribers, support staff, pharmacies) with fair balance on proper placement within the treatment continuum. Participates in and contributes product and disease state knowledge during sales and marketing meetings, training programs, conventions and displays as appropriate. Physical Requirements Driver must maintain a valid driver’s license. Must be in good standing by not exceeding the Novo Nordisk points threshold assigned based on review of Motor Vehicle Records. Qualifications Bachelor’s or equivalent degree, and/or Pharm D required Minimum one (1) year of experience working in one or more of the following areas preferred: Pharmaceutical/Healthcare, Sales, Consulting, Customer Service or Military Intermediate computer skills required (Windows, Word, Excel); Prior computer experience using sales data/call reporting software ideal Must be a self-starter and be able to evaluate options and make decisions on your own with minimal supervision Aptitude for leadership and decision-making ability Solid understanding of current therapy areas (diabetes and obesity) and Novo Nordisk’s products is needed, coupled with aptitude for learning and ability to communicate technical and scientific product and disease management information This position is part of a job family. Title and level within the job family are evaluated based on a number of factors, such as years of experience, scope of work, proficiency, and business need. Candidates will be assessed for the most appropriate title and level within the job family during the recruitment process. The base range of pay for each title in this job family are as follows: CMCS I - $101,000 to $124,000 CMCS II - $125,000 to $153,000 SR CMCS - $139,000 to $170,000 In addition, this position is eligible for a company bonus based on individual and company performance. Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the position’s level or other company factors. Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flexible vacation policy, and parental leave policy. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations. If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at View phone number on click.appcast.io. This contact is for accommodation requests only and cannot be used to inquire about the status of applications. #J-18808-Ljbffr Initial Therapeutics, Inc.